0001181431-13-023067.txt : 20130422 0001181431-13-023067.hdr.sgml : 20130422 20130422190220 ACCESSION NUMBER: 0001181431-13-023067 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130418 FILED AS OF DATE: 20130422 DATE AS OF CHANGE: 20130422 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lockshin Curtis CENTRAL INDEX KEY: 0001383556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54910 FILM NUMBER: 13774860 MAIL ADDRESS: STREET 1: 4400 BISCAYNE BOULEVARD STREET 2: SUITE 950 CITY: MIAMI STATE: FL ZIP: 33137 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RXi Pharmaceuticals Corp CENTRAL INDEX KEY: 0001533040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1500 WEST PARK DRIVE STREET 2: SUITE 210 CITY: WESTBOROUGH STATE: MA ZIP: 01581 BUSINESS PHONE: (508) 767-3861 MAIL ADDRESS: STREET 1: 1500 WEST PARK DRIVE STREET 2: SUITE 210 CITY: WESTBOROUGH STATE: MA ZIP: 01581 4 1 rrd377323.xml FORM 4 X0306 4 2013-04-18 0 0001533040 RXi Pharmaceuticals Corp RXII 0001383556 Lockshin Curtis C/O RXI PHARMACEUTICALS CORPORATION 1500 WEST PARK DRIVE, SUITE 210 WESTBOROUGH MA 01581 1 0 0 0 Stock Option (right to buy) 0.2395 2013-04-18 4 A 0 1000000 0 A 2023-04-18 Common stock 1000000 1000000 D The award will vest in equal quarterly installments of 250,000 shares on each of June 30, 2013, September 30, 2013, December 31, 2013, and March 31, 2014. /s/ Caitlin Kontulis, attorney-in-fact 2013-04-22